Pontoriero 1999.
Methods | 1‐year follow‐up split‐mouth study including 4 parallel arms with 40 patients in total. Only 2 parallel arms evaluated. No drop outs at 1 year. | |
Participants | Patients in good general health and motivated for good oral hygiene. Teeth with PPD greater or equal to 6 mm and IBD greater or equal to 3 mm. In 2 groups, however, defects shallower than 3 mm were included and therefore were excluded from the present review. Age ranging between 32‐61; 15 males and 25 females recruited in 1 private practice. | |
Interventions | 4 split‐mouth groups were included: (1) GTR with Guidor resorbable barriers versus flap surgery; (2) GTR with Resolut resorbable barriers versus flap surgery; (3) GTR with Gore‐Tex non‐resorbable barriers versus flap surgery; (4) Emdogain versus flap surgery and placebo. We analysed only groups (3) and (4) since in the other 2 groups defects shallower than 3 mm were included. | |
Outcomes | FMPS, BOP and for experimental teeth only: PAL, PPD, REC at baseline and 1 year. Tooth loss and postoperative infections. Additional intrasurgical measurements were taken. 1‐year data used. | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Quote: "The 40 subjects were randomly divided into 4 treatment groups including 10 subjects each: 3 membrane groups and one Emdogain® group". |
Allocation concealment (selection bias) | Unclear risk | Author informed us that allocation to intervention group was concealed, but did not explain how. |
Blinding (performance bias and detection bias) All outcomes | Low risk | Author informed us that both the outcome assessor and the patients were blinded to which site received which treatment. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Outcome data on PAL, PPD and REC are presented in Table 2: Result of GTR and Emdogain® therapy. Comment: No missing data. No drop outs. |
Selective reporting (reporting bias) | Low risk | All pre‐specified outcomes are reported in Tables 2 and 4. Comment: Only data from the Gore‐Tex® and Emdogain® groups (3 and 4) are included in this review. Data from the other 2 groups had to be excluded on the basis of not meeting the 3 mm intrabony defect criterion. The author informed us that no teeth were extracted and no postoperative complication was reported. Changes in bone level and aesthetics were not evaluated as treatment outcomes. |
Other bias | Low risk | No other source of bias can be identified. |